DK1007052T3 - Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelse - Google Patents
Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelseInfo
- Publication number
- DK1007052T3 DK1007052T3 DK98942166T DK98942166T DK1007052T3 DK 1007052 T3 DK1007052 T3 DK 1007052T3 DK 98942166 T DK98942166 T DK 98942166T DK 98942166 T DK98942166 T DK 98942166T DK 1007052 T3 DK1007052 T3 DK 1007052T3
- Authority
- DK
- Denmark
- Prior art keywords
- progesterones
- oral contraception
- endometrically
- atrophizing
- sparing
- Prior art date
Links
- 239000000262 estrogen Substances 0.000 title abstract 3
- 229940011871 estrogen Drugs 0.000 title abstract 3
- 239000000186 progesterone Substances 0.000 title 2
- 150000003146 progesterones Chemical class 0.000 title 2
- 230000002357 endometrial effect Effects 0.000 title 1
- 239000000583 progesterone congener Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 210000004696 endometrium Anatomy 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5710997P | 1997-08-27 | 1997-08-27 | |
| EP98942166A EP1007052B1 (en) | 1997-08-27 | 1998-08-20 | Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception |
| PCT/US1998/017288 WO1999009993A1 (en) | 1997-08-27 | 1998-08-20 | Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1007052T3 true DK1007052T3 (da) | 2005-01-31 |
Family
ID=22008560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98942166T DK1007052T3 (da) | 1997-08-27 | 1998-08-20 | Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelse |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1007052B1 (enExample) |
| JP (1) | JP2001513566A (enExample) |
| AT (1) | ATE279198T1 (enExample) |
| AU (1) | AU9028098A (enExample) |
| DE (1) | DE69827017T2 (enExample) |
| DK (1) | DK1007052T3 (enExample) |
| ES (1) | ES2230711T3 (enExample) |
| PT (1) | PT1007052E (enExample) |
| WO (1) | WO1999009993A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
| WO2001030355A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
| CA2524474A1 (en) * | 2003-05-02 | 2004-11-18 | Duramed Pharmaceuticals, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
| JP2007534622A (ja) * | 2003-07-16 | 2007-11-29 | デュラメド ファーマシューティカルズ インコーポレーティッド | 連続的エストロゲン投与での避妊薬療法を利用するホルモン処置の方法 |
| JP2007507534A (ja) * | 2003-10-01 | 2007-03-29 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 持続的三相避妊方法 |
| EP1535618A1 (en) | 2003-11-26 | 2005-06-01 | Schering Aktiengesellschaft | Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4390531A (en) * | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
| US4921843A (en) * | 1988-10-20 | 1990-05-01 | Pasquale Samuel A | Contraception system and method |
| US4616006A (en) * | 1983-09-26 | 1986-10-07 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| IE61236B1 (en) * | 1986-07-15 | 1994-10-19 | American Home Prod | Combination dosage form for pre-menopausal women |
| FI101601B1 (fi) * | 1987-09-24 | 1998-07-31 | Jencap Research Ltd | Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmisteen valmistusmenetelmässä |
| DE4104385C1 (enExample) * | 1991-02-09 | 1992-08-13 | Marika Dr.Med. 6509 Framersheim De Ehrlich |
-
1998
- 1998-08-20 JP JP2000507383A patent/JP2001513566A/ja not_active Ceased
- 1998-08-20 AT AT98942166T patent/ATE279198T1/de active
- 1998-08-20 EP EP98942166A patent/EP1007052B1/en not_active Expired - Lifetime
- 1998-08-20 ES ES98942166T patent/ES2230711T3/es not_active Expired - Lifetime
- 1998-08-20 DE DE69827017T patent/DE69827017T2/de not_active Expired - Lifetime
- 1998-08-20 AU AU90280/98A patent/AU9028098A/en not_active Abandoned
- 1998-08-20 WO PCT/US1998/017288 patent/WO1999009993A1/en not_active Ceased
- 1998-08-20 DK DK98942166T patent/DK1007052T3/da active
- 1998-08-20 PT PT98942166T patent/PT1007052E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001513566A (ja) | 2001-09-04 |
| ES2230711T3 (es) | 2005-05-01 |
| DE69827017D1 (de) | 2004-11-18 |
| EP1007052A1 (en) | 2000-06-14 |
| AU9028098A (en) | 1999-03-16 |
| WO1999009993A1 (en) | 1999-03-04 |
| ATE279198T1 (de) | 2004-10-15 |
| PT1007052E (pt) | 2005-01-31 |
| DE69827017T2 (de) | 2006-03-09 |
| EP1007052B1 (en) | 2004-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR970704430A (ko) | 전립선 질환, 자궁내막증 및 비만증의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of prostatic diseases endometriosis and obesity) | |
| CY2009015I2 (el) | Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο | |
| ES2132645T3 (es) | Uso en una composicion farmaceutica. | |
| NO20003546L (no) | Anvendelse av progestin og en farmasøytisk sammensetning samt et kit inneholdende disse | |
| TR199901417T2 (xx) | Analjezik etkisi olan yeni bile�imler. | |
| MX9203278A (es) | Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina. | |
| FI20115742L (fi) | Mometasonifuroaatin käyttö lääkkeen valmistuksessa | |
| LU91429I2 (fr) | "Furoate de fluticasone et ses solvates(AVAMYS)" | |
| ID22565A (id) | Penggunaan nanodispersi dalam formulasi akhir obat | |
| FI972642L (fi) | Galeeninen yksikkökoostumus käytettäväksi paikallisesti hedelmöityksen ehkäisyyn ja/tai sukupuoliteitse välittyvien sairauksien ja/tai HIV:n vastaiseen taisteluun | |
| AU2002227184A1 (en) | Methods for development and use of diagnostic and therapeutic agents | |
| ES2097748T3 (es) | Uso de derivados funcionales de la molecula de adhesion intercelular icam-1 en la terapia antivirica. | |
| IL141235A0 (en) | Combined use of an alpha-adrenoceptor antagonist and amuscarinic antagonist in the treatment of benign prostatic hyperplasi | |
| NO20004419L (no) | Ny anvendelse | |
| UA37259C2 (uk) | Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч | |
| TR199801511T2 (xx) | Farmas�tik bile�im. | |
| NO308581B1 (no) | Anvendelse av et antiprogestin og et progestin ved fremstilling av et medikament, implantat samt prevensjonssett inneholdende disse | |
| NO20025157L (no) | Kreftterapi | |
| NO995657D0 (no) | Kombinasjonsterapi for endring av human seksuell respons | |
| DK1007052T3 (da) | Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelse | |
| AR030140A1 (es) | Composiciones derivadas de la 2-piridinamina y metodos relacionados | |
| NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
| NO20001717D0 (no) | Serotonin-inneholdende formulering for oral administrering og anvendelse av samme | |
| DE69612056D1 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
| AU1518902A (en) | Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |